-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Allspring Global Investments Holdings LLC
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC grew its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO – Get Rating) by 0.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,645 shares of the medical instruments supplier's stock after purchasing an additional 1,560 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.43% of AngioDynamics worth $3,409,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently made changes to their positions in ANGO. Victory Capital Management Inc. lifted its stake in AngioDynamics by 3.4% during the second quarter. Victory Capital Management Inc. now owns 2,933,155 shares of the medical instruments supplier's stock valued at $56,757,000 after purchasing an additional 96,263 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of AngioDynamics by 1.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,750,872 shares of the medical instruments supplier's stock valued at $59,255,000 after acquiring an additional 46,173 shares during the last quarter. Polar Capital Holdings Plc boosted its stake in shares of AngioDynamics by 21.6% during the 1st quarter. Polar Capital Holdings Plc now owns 1,882,375 shares of the medical instruments supplier's stock worth $40,546,000 after acquiring an additional 334,649 shares in the last quarter. FMR LLC grew its holdings in shares of AngioDynamics by 7.7% in the 2nd quarter. FMR LLC now owns 1,813,546 shares of the medical instruments supplier's stock worth $35,093,000 after acquiring an additional 130,429 shares during the last quarter. Finally, Loomis Sayles & Co. L P raised its position in shares of AngioDynamics by 10.6% during the second quarter. Loomis Sayles & Co. L P now owns 1,400,992 shares of the medical instruments supplier's stock worth $27,109,000 after purchasing an additional 134,075 shares during the period. Institutional investors and hedge funds own 94.94% of the company's stock.
Get AngioDynamics alerts:AngioDynamics Stock Performance
Shares of AngioDynamics stock opened at $13.83 on Wednesday. AngioDynamics, Inc. has a 12 month low of $11.71 and a 12 month high of $24.87. The company has a quick ratio of 1.30, a current ratio of 2.16 and a debt-to-equity ratio of 0.12. The stock has a market cap of $541.22 million, a PE ratio of -16.66 and a beta of 0.66. The business has a fifty day simple moving average of $13.38 and a 200-day simple moving average of $17.59.
Analyst Ratings Changes
A number of research firms recently weighed in on ANGO. StockNews.com started coverage on AngioDynamics in a research report on Wednesday, October 12th. They issued a "hold" rating for the company. Raymond James dropped their target price on shares of AngioDynamics from $25.00 to $22.00 and set a "strong-buy" rating on the stock in a research report on Friday, January 6th.AngioDynamics Company Profile
(Get Rating)
AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally.
See Also
- Get a free copy of the StockNews.com research report on AngioDynamics (ANGO)
- Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
- Can Alaska Air Continue Soaring Above The Airline Industry?
- Insulet Has Potential To Gain More Than Analysts Are Forecasting
- Cathie Wood Is Buying These Stocks, Should You?
- Tritium Is the Largest DC EV Charger Maker You've Never Heard Of
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
据AngioDynamics,Inc.(纳斯达克代码:Ango-Get Rating)在最近提交给美国证券交易委员会的文件中称,AllSpring Global Investments Holdings LLC在第三季度增持了该公司的股票0.9%。该机构投资者持有这家医疗器械供应商的166,645股股票,在此期间又购买了1,560股。截至最近提交给证券交易委员会的文件,AllSpring Global Investments Holdings LLC拥有AngioDynamics约0.43%的股份,价值3,409,000美元。
其他几家对冲基金最近也调整了在Ango的头寸。胜利资本管理公司在第二季度增持了3.4%的AngioDynamic股份。胜利资本管理公司现在拥有这家医疗器械供应商2933,155股股票,价值56,757,000美元,在上个季度又购买了96,263股。Dimension Fund Advisors LP在第一季度将其在AngioDynamic股票的头寸提高了1.7%。Dimension Fund Advisors LP现在拥有这家医疗器械供应商的2,750,872股股票,价值59,255,000美元,在上个季度额外收购了46,173股。Polal Capital Holdings Plc在第一季度增持了21.6%的AngioDynamic股票。Polal Capital Holdings Plc在上个季度额外收购了334,649股后,现在拥有这家医疗器械供应商价值40,546,000美元的股票1,882,375股。FMR LLC在第二季度增持了7.7%的AngioDynamic股票。FMR LLC现在拥有这家医疗器械供应商1,813,546股股票,价值35,093,000美元,上个季度又收购了130,429股。最后,Loomis Sayles&Co.L P在第二季度将其在AngioDynamic的股票头寸提高了10.6%。Loomis Sayles&Co.L P现在持有这家医疗器械供应商1,400,992股股票,价值27,109,000美元,在此期间又购买了134,075股。机构投资者和对冲基金持有该公司94.94%的股票。
到达血管动力学警报:AngioDynamic股票表现
周三,AngioDynamics的股票开盘报13.83美元。AngioDynamic,Inc.的12个月低点为11.71美元,12个月高位为24.87美元。该公司的速动比率为1.30,流动比率为2.16,债务权益比率为0.12。该股市值为5.4122亿美元,市盈率为-16.66,贝塔系数为0.66。该业务的50日简单移动均线切入位为13.38美元,200日简单移动均线切入位为17.59美元。
分析师评级发生变化
一些研究公司最近对Ango发表了看法。StockNews.com在10月12日星期三的一份研究报告中开始报道AngioDynamic。他们对该公司的评级为“持有”。雷蒙德·詹姆斯在1月6日星期五的一份研究报告中将AngioDynamic的目标价从25.00美元下调至22.00美元,并将该股的评级定为“强力买入”。AngioDynamics公司简介
(获取评级)
AngioDynamic公司设计、制造和销售各种医疗、手术和诊断设备,由专业保健提供商用于治疗外周血管疾病和血管通路,并用于美国和国际上的肿瘤学和外科环境。
另请参阅
- 免费获取StockNews.com关于血管动力学的研究报告(Ango)
- 强生的突破:盈利能提振股市吗?
- 阿拉斯加航空能否继续在航空业之上高歌猛进?
- Insulet有潜力获得超过分析师预测的收益
- 凯西·伍德正在购买这些股票,你应该这样做吗?
- 氚是你从未听说过的最大的DC电动汽车充电器制造商
接受《血管动力学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对AngioDynamic和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧